semaglutide 7.2 mg clinical trial Once-weekly 7·2 in adults with obesity (STEP UP): a randomised, controlled, phase 3b STEP UP: Semaglutide 7.2mg achieves

The move was meant to reduce spending on weight loss drugs for the insurer, which recently laid off 110 people, or 2 percent of its workforce, as its finances deteriorated

[11] Tirzepatide Once Weekly for the Treatment of Obesity | New England Journal of Medicine. Accessed: Nov

Positive routines, like balanced meals and steady sleep, make it easier to manage weight even after reaching a maintenance dose

Provider-guided programs to help support appetite awareness and sustainable daily habits safely

This requirement creates particular challenges in regions with unreliable electricity, hot climates, or limited access to medical-grade refrigeration